Chinese COVID-19 vaccine safely induces immune response

Preliminary results on a phase 1/2 trial of the inactivated whole SARS-CoV-2 virus.
Preliminary results on a phase 1/2 trial of the inactivated whole SARS-CoV-2 virus.